Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;2(4):265-71.
doi: 10.4103/2278-330X.119893.

Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India

Sushma Agrawal  1
Affiliations

Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India

Sushma Agrawal. South Asian J Cancer. 2013 Oct.

Abstract

Data supporting use of concurrent chemoradiation in locally advanced lung cancers comes from clinical trials from developed countries. Applicability and outcomes of such schedules in developing countries is not widely reported. There are various challenges in delivering chemoradiation in locally advanced non small cell lung cancer in developing countries which is highlighted by an audit of patients treated with chemoradiation in our center. This article deals with the challenges in the context of a developing country. We conclude that sequential chemoradiotherapy is better tolerated than concurrent chemoradiation in Indian patients with locally advanced non-small cell lung cancers. Patients with stage IIIa, normal weight or overweight, and adequate baseline pulmonary function should be offered concurrent chemoradiation.

Keywords: Locally advanced non-small cell Lung cancer; chemoradiation; concurrent chemoradiation; developing countries; non-small-cell lung cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

See all similar articles

Cited by

  • Potential for adaptive dose escalation in radiotherapy for patients with locally advanced non-small-cell lung cancer in a low mid income setting.
    Agrawal S, Kumar S, Maurya AK. Agrawal S, et al. Br J Radiol. 2017 Feb;90(1070):20140234. doi: 10.1259/bjr.20140234. Epub 2017 Jan 3. Br J Radiol. 2017. PMID: 27897060 Free PMC article.
  • Uniqueness of lung cancer in Southeast Asia.
    Noronha V, Budukh A, Chaturvedi P, Anne S, Punjabi A, Bhaskar M, Sahoo TP, Menon N, Shah M, Batra U, Nathany S, Kumar R, Shetty O, Ghodke TP, Mahajan A, Chakrabarty N, Hait S, Tripathi SC, Chougule A, Chandrani P, Tripathi VK, Jiwnani S, Tibdewal A, Maheshwari G, Kothari R, Patil VM, Bhat RS, Khanderia M, Mahajan V, Prakash R, Sharma S, Jabbar AA, Yadav BK, Uddin AFMK, Dutt A, Prabhash K. Noronha V, et al. Lancet Reg Health Southeast Asia. 2024 Jul 8;27:100430. doi: 10.1016/j.lansea.2024.100430. eCollection 2024 Aug. Lancet Reg Health Southeast Asia. 2024. PMID: 39157507 Free PMC article. Review.

References

    1. Ferlay J, Bray F, Pisani P, Parkin DM. IARC Cancer Base No 5. Version 2.0. Lyon: IARC Press; 2004. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide.
    1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
    1. National Cancer Registry Programme (NCRP) A Consolidated report of the population based cancer registries data, cancer statistics 2002-2006, Indian Council of Medical Research, New Delhi
    1. Behera D, Balamugesh T. Lung cancer in India. Indian J Chest Dis Allied Sci. 2004;46:269–81. - PubMed
    1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ. 1995;311:899–909. - PMC - PubMed